LOGO
LOGO

Article Search

Discover the power of RTTNews website's advanced search page, designed for seamless Article retrieval by Company Name, Stock Symbol, and other criteria.
Stay updated with the Latest News on specific Companies, Financial Insights, and Market Trends. We Ensure you to get the most relevant information instantly.

Symbol  
Company  
Currency Symbol   eg (EUR/USD)
Keyword  
  • KalVista Announces Orphan Drug Designation And NDA Submission For Sebetralstat In Japan For Hereditary Angioedema 1/21/2025 7:08:43 AM
  • KalVista Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) 1/8/2025 6:34:01 AM
  • KalVista Pharmaceuticals Appoints Jeb Ledell As Chief Operating Officer 12/16/2024 7:07:58 AM
  • KalVista Pharmaceuticals Q2 Net Loss/shr $0.91 Vs. Loss/shr $0.80 Last Year 12/5/2024 6:45:41 AM
  • KalVista Pharma Reports Inducement Grants Under Nasdaq Listing Rule 11/5/2024 6:42:22 AM
  • KalVista Pharma Appoints Brian Piekos As CFO 9/10/2024 6:33:12 AM
  • KalVista Pharmaceuticals Presents Sebetralstat Data At Bradykinin Symposium 2024 9/6/2024 6:34:18 AM
  • KalVista Pharma Q1 Net Loss $40.4 Mln Or $0.87/Shr Vs Loss Of $25.3 Mln Or $0.74/Shr Last Year 9/5/2024 6:34:16 AM
  • KalVista Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) 9/4/2024 6:37:13 AM
  • KalVista Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) 8/2/2024 6:38:47 AM
  • KalVista Pharma Announces Pricing Of $160.1 Mln Public Offering Of Common Stock And Pre-Funded Warrants 2/15/2024 6:34:55 AM
Copyright © 2026 RTTNews. All rights reserved. By using this site, you agree to the Terms of Service. About Us   |   Contact Us   |   Privacy   |   Sitemap